Respiratory Syncytial Virus causes severe respiratory tract infections and worldwide claims the lives of 160,000 children each year. Scientists have succeeded in developing a promising vaccination strategy to counteract this common virus infection. “We discovered a new vaccination strategy that paves the way for the development of a novel approach to vaccination against RSV, a virus that causes suffering in numerous small children and elderly people,” experts report.

Source: Respiratory Syncytial Virus: New perspectives for development of a vaccine


David Cottle

UBB Owner & Administrator